Oncologist preferences for health States associated with the treatment of advanced ovarian cancer - (interview with 34 oncologists) - abstract

Objective:
"To explore oncologists' preferences for hypothetical outcome scenarios (i.e. health states) resulting from various treatment options."
Conclusions:
"These data suggest that oncologists may choose treatments that maximize clinical efficacy only when not associated with severe toxicities or low emotional well-being unless associated with a large improvement in efficacy. Physicians may prefer a more toxic chemotherapy regimen that improves survival, and are more willing to compromise emotional well-being for a large survival advantage in the setting of newly diagnosed disease. Slight improvements in clinical efficacy may not be acceptable to oncologists unless associated with higher emotional well-being for the patient."